{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T04:23:11Z","timestamp":1787977391121,"version":"build-2784847793"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T00:00:00Z","timestamp":1647993600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Estimations of Lyme disease incidence rates in the United Kingdom vary. There is evidence that this disease is associated with fatigue in its early stage but reports are contradictory as far as long-term fatigue is concerned.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods and findings<\/jats:title>\n                    <jats:p>A population-based historical cohort study was conducted on patients treated in general practices contributing to IQVIA Medical Research Data: 2,130 patients with a first diagnosis of Lyme disease between 2000 and 2018 and 8,510 randomly-sampled patients matched by age, sex, and general practice, followed-up for a median time of 3 years and 8 months. Main outcome measure was time to consultation for (1) any fatigue-related symptoms or diagnosis; or (2) myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS). Adjusted hazard ratios (HRs) were estimated from Cox models. Average incidence rate for Lyme disease across the UK was 5.18 per 100,000 person-years, increasing from 2.55 in 2000 to 9.33 in 2018. In total, 929 events of any types of fatigue were observed, leading to an incidence rate of 307.90 per 10,000 person-years in the Lyme cohort (282 events) and 165.60 in the comparator cohort (647 events). Effect of Lyme disease on any subsequent fatigue varied by index season: adjusted HRs were the highest in autumn and winter with 3.14 (95%CI: 1.92\u20135.13) and 2.23 (1.21\u20134.11), respectively. For ME\/CFS, 17 events were observed in total. Incidence rates were 11.76 per 10,000 person-years in Lyme patients (12 events) and 1.20 in comparators (5 events), corresponding to an adjusted HR of 16.95 (5.17\u201355.60). Effects were attenuated 6 months after diagnosis but still clearly visible.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>UK primary care records provided strong evidence that Lyme disease was associated with subsequent fatigue and ME\/CFS. Albeit weaker on the long-term, these effects persisted beyond 6 months, suggesting patients and healthcare providers should remain alert to fatigue symptoms months to years following Lyme disease diagnosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0265765","type":"journal-article","created":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T13:32:38Z","timestamp":1648042358000},"page":"e0265765","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["Incidence of Lyme disease in the United Kingdom and association with fatigue: A population-based, historical cohort study"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0143-472X","authenticated-orcid":true,"given":"Florence","family":"Brellier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1375-1028","authenticated-orcid":true,"given":"Mar","family":"Pujades-Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9427-9468","authenticated-orcid":true,"given":"Emma","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7950-8680","authenticated-orcid":true,"given":"Kathleen","family":"Mudie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5077-7868","authenticated-orcid":true,"given":"Eliana","family":"Mattos Lacerda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1411-8088","authenticated-orcid":true,"given":"Luis","family":"Nacul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2335-9641","authenticated-orcid":true,"given":"Kevin","family":"Wing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,3,23]]},"reference":[{"issue":"1","key":"pone.0265765.ref001","first-page":"74","article-title":"An estimate of Lyme borreliosis incidence in Western Europe\u2020.","volume":"39","author":"RA Sykes","year":"2017","journal-title":"J Public Health Oxf Engl"},{"key":"pone.0265765.ref002","unstructured":"Public Health England. DEFRA. Zoonoses Report UK 2017 [Internet]. [Internet]. 2018. Available from: https:\/\/www.gov.uk\/government\/publications\/zoonoses-uk-annual-reports"},{"issue":"3","key":"pone.0265765.ref003","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.diagmicrobio.2016.07.026","article-title":"Fatigue in patients with erythema migrans","volume":"86","author":"GP Wormser","year":"2016","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"1","key":"pone.0265765.ref004","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ttbdis.2018.09.012","article-title":"Somatic symptoms and fatigue in a Norwegian population with high exposure to ticks.","volume":"10","author":"ET Thortveit","year":"2019","journal-title":"Ticks Tick-Borne Dis."},{"issue":"2","key":"pone.0265765.ref005","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.amjmed.2014.09.022","article-title":"Long-term Assessment of Fatigue in Patients with Culture-confirmed Lyme Disease","volume":"128","author":"GP Wormser","year":"2015","journal-title":"Am J Med"},{"issue":"3","key":"pone.0265765.ref006","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1086\/318082","article-title":"Evaluation of Study Patients with Lyme Disease, 10\u201320-Year Follow-up","volume":"183","author":"RA Kalish","year":"2001","journal-title":"J Infect Dis"},{"issue":"5","key":"pone.0265765.ref007","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1600-0404.2010.01482.x","article-title":"European neuroborreliosis: quality of life 30 months after treatment.","volume":"124","author":"R Eikeland","year":"2011","journal-title":"Acta Neurol Scand"},{"key":"pone.0265765.ref008","doi-asserted-by":"crossref","first-page":"826","DOI":"10.3389\/fneur.2020.00826","article-title":"How Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome (ME\/CFS) Progresses: The Natural History of ME\/CFS.","volume":"11","author":"L Nacul","year":"2020","journal-title":"Front Neurol"},{"issue":"2","key":"pone.0265765.ref009","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1136\/jcp.2006.042754","article-title":"Definitions and aetiology of myalgic encephalomyelitis: how the Canadian consensus clinical definition of myalgic encephalomyelitis works","volume":"60","author":"BM Carruthers","year":"2007","journal-title":"J Clin Pathol"},{"issue":"4","key":"pone.0265765.ref010","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1365-2796.2011.02428.x","article-title":"Myalgic encephalomyelitis: International Consensus Criteria","volume":"270","author":"BM Carruthers","year":"2011","journal-title":"J Intern Med"},{"key":"pone.0265765.ref011","unstructured":"Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome, Board on the Health of Select Populations, Institute of Medicine. Beyond Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome: Redefining an Illness [Internet]. Washington (DC): National Academies Press (US); 2015 [cited 2021 Nov 3]. (The National Academies Collection: Reports funded by National Institutes of Health). Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK274235\/"},{"issue":"5","key":"pone.0265765.ref012","doi-asserted-by":"crossref","first-page":"E1557","DOI":"10.3390\/jcm9051557","article-title":"Systematic Review of the Epidemiological Burden of Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome Across Europe: Current Evidence and EUROMENE Research Recommendations for Epidemiology.","volume":"9","author":"F Est\u00e9vez-L\u00f3pez","year":"2020","journal-title":"J Clin Med."},{"issue":"2","key":"pone.0265765.ref013","first-page":"E88","article-title":"The Development of a Consistent Europe-Wide Approach to Investigating the Economic Impact of Myalgic Encephalomyelitis (ME\/CFS): A Report from the European Network on ME\/CFS (EUROMENE).","volume":"8","author":"DFH Pheby","year":"2020","journal-title":"Healthc Basel Switz."},{"issue":"3","key":"pone.0265765.ref014","first-page":"171","article-title":"Feasibility study and methodology to create a quality-evaluated database of primary care data.","volume":"12","author":"A Bourke","year":"2004","journal-title":"Inform Prim Care"},{"issue":"4","key":"pone.0265765.ref015","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/pds.1335","article-title":"Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research.","volume":"16","author":"JD Lewis","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf."},{"issue":"1","key":"pone.0265765.ref016","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/pds.1688","article-title":"The importance of defining periods of complete mortality reporting for research using automated data from primary care.","volume":"18","author":"A Maguire","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf."},{"issue":"8","key":"pone.0265765.ref017","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1086\/521256","article-title":"Reinfection in patients with Lyme disease","volume":"45","author":"RB Nadelman","year":"2007","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"7","key":"pone.0265765.ref018","doi-asserted-by":"crossref","first-page":"e025916","DOI":"10.1136\/bmjopen-2018-025916","article-title":"Incidence of Lyme disease in the UK: a population-based cohort study","volume":"9","author":"V Cairns","year":"2019","journal-title":"BMJ Open"},{"issue":"1","key":"pone.0265765.ref019","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1186\/s12889-019-7245-8","article-title":"Characteristics and patient pathways of Lyme disease patients: a retrospective analysis of hospital episode data in England and Wales (1998\u20132015).","volume":"19","author":"JSP Tulloch","year":"2019","journal-title":"BMC Public Health."},{"key":"pone.0265765.ref020","unstructured":"NICE. Lyme disease NICE guideline [Internet]. [Internet]. 2018. Available from: https:\/\/www.nice.org.uk\/guidance\/ng95"},{"key":"pone.0265765.ref021","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.3389\/fneur.2018.01026","article-title":"The UK ME\/CFS Biobank: A Disease-Specific Biobank for Advancing Clinical Research Into Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome","volume":"9","author":"EM Lacerda","year":"2018","journal-title":"Front Neurol"},{"issue":"11","key":"pone.0265765.ref022","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1111\/ene.13088","article-title":"Ongoing impairments following transient ischaemic attack: retrospective cohort study","volume":"23","author":"GM Turner","year":"2016","journal-title":"Eur J Neurol"},{"issue":"27","key":"pone.0265765.ref023","doi-asserted-by":"crossref","first-page":"4696","DOI":"10.1002\/sim.5879","article-title":"Ignoring the matching variables in cohort studies\u2013when is it valid and why?","volume":"32","author":"A Sj\u00f6lander","year":"2013","journal-title":"Stat Med."},{"issue":"6","key":"pone.0265765.ref024","doi-asserted-by":"crossref","first-page":"e1002037","DOI":"10.1371\/journal.pmed.1002037","article-title":"Phosphodiesterase Type 5 Inhibitors and Risk of Malignant Melanoma: Matched Cohort Study Using Primary Care Data from the UK Clinical Practice Research Datalink.","volume":"13","author":"A Matthews","year":"2016","journal-title":"PLoS Med."},{"issue":"1","key":"pone.0265765.ref025","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00415-015-7923-0","article-title":"Prevalence and spectrum of residual symptoms in Lyme neuroborreliosis after pharmacological treatment: a systematic review","volume":"263","author":"R Dersch","year":"2016","journal-title":"J Neurol"},{"key":"pone.0265765.ref026","doi-asserted-by":"crossref","unstructured":"The Diagnostic Error in Medicine 12th Annual International Conference. Diagnosis. 2019 Nov 26;6(4):eA1\u201396.","DOI":"10.1515\/dx-2019-0075"},{"issue":"6","key":"pone.0265765.ref027","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/qjmed\/hcs003","article-title":"Lyme disease in a British referral clinic","volume":"105","author":"LE Cottle","year":"2012","journal-title":"QJM"},{"key":"pone.0265765.ref028","first-page":"w14353","article-title":"Update of the Swiss guidelines on post-treatment Lyme disease syndrome.","volume":"146","author":"J Nemeth","year":"2016","journal-title":"Swiss Med Wkly."},{"issue":"11","key":"pone.0265765.ref029","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1001\/archneur.1997.00550230045015","article-title":"Post-Lyme syndrome and chronic fatigue syndrome. Neuropsychiatric similarities and differences","volume":"54","author":"EA Gaudino","year":"1997","journal-title":"Arch Neurol"},{"issue":"2","key":"pone.0265765.ref030","doi-asserted-by":"crossref","first-page":"e17287","DOI":"10.1371\/journal.pone.0017287","article-title":"Distinct cerebrospinal fluid proteomes differentiate post-treatment lyme disease from chronic fatigue syndrome.","volume":"6","author":"SE Schutzer","year":"2011","journal-title":"PloS One."},{"issue":"4","key":"pone.0265765.ref031","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ttbdis.2015.03.017","article-title":"U.S. public\u2019s experience with ticks and tick-borne diseases: Results from national HealthStyles surveys.","volume":"6","author":"SA Hook","year":"2015","journal-title":"Ticks Tick-Borne Dis.Jun"},{"issue":"1","key":"pone.0265765.ref032","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/s12883-019-1468-2","article-title":"A logistic regression analysis of risk factors in ME\/CFS pathogenesis.","volume":"19","author":"EM Lacerda","year":"2019","journal-title":"BMC Neurol."}],"updated-by":[{"DOI":"10.1371\/journal.pone.0274408","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T00:00:00Z","timestamp":1662422400000}}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0265765","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T13:33:26Z","timestamp":1648042406000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0265765"}},"subtitle":[],"editor":[{"given":"Utpal","family":"Pal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,3,23]]},"references-count":32,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,3,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0265765","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.07.21.21251509","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,23]]}}}